UPDATE 5-Glaxo boosted by drug comebacks, Q1 earnings

home   >   MSN news

market by the middle of this year after signing a legal agreement with regulators over a problem plant in Puerto Rico. ... on Thursday, driven by strong sales of asthma drug Advair and Avandia for diabetes, extending early gains in the stock ...

- link to UPDATE 5-Glaxo boosted by drug comebacks, Q1 earnings -
Last update: 05/26/2005

Recommended Reading

    Advair diskus 250/50.(New & Approved) : An article from: Internal Medicine News
    FDA Panel Backs Combination Steroid-Bronchodilator Inhaler.(Brief Article)(Statistical Data Included) : An article from: Family Practice News
    Advair Diskus. : An article from: Family Practice News
    Advair diskus 250/50.(New & Approved) : An article from: Internal Medicine News
    FDA Panel Backs Combination Steroid-Bronchodilator Inhaler.(Brief Article)(Statistical Data Included) : An article from: Family Practice News
    Advair beats combivent for patients with COPD.(Pulmonary Medicine)(chronic obstructive pulmonary disease) : An article from: Internal Medicine News
    Advair Diskus bests Combivent for COPD.(Pulmonary Medicine)(chronic obstructive pulmonary disease ) : An article from: Family Practice News
    New and approved: Nasacort HFA Nasal Aerosol, Advair Diskus.(Rx) : An article from: Family Practice News